Skip to main content

Shah Gaurav

In the past year, 8 open-market sale filings worth $285.9K and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$285.9K
8 filings
Net
−$285.9K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Shah Gaurav as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

RCKT Rocket Pharmaceuticals, Inc.

CEO20 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Feb 8, 2022 (view filing)Feb 71 dayShah GauravCEOPPurchase+22.0K$17.34+$381.5K+4.4%517.6K after
Feb 22, 2023 (view filing)Feb 175 daysShah GauravCEOSSale−12.2K$19.06−$232.4K−2.2%536.9K after
May 19, 2023 (view filing)May 172 daysShah GauravCEOSSale−4.12K$21.38−$88.1K−0.8%521.6K after
Aug 21, 2023 (view filing)Aug 174 daysShah GauravCEOSSale−4.77K$15.47−$73.7K−0.9%524.9K after
Feb 21, 2024 (view filing)Feb 165 daysShah GauravCEOSSale−20.3K$29.84−$604.9K−3.5%554.8K after
May 20, 2024 (view filing)May 164 daysShah GauravCEOSSale−9.79K$23.35−$228.6K−1.3%728.1K after
Aug 20, 2024 (view filing)Aug 164 daysShah GauravCEOSSale−9.65K$18.50−$178.5K−1.3%718.4K after
Nov 25, 2024 (view filing)Nov 214 daysShah GauravCEOSSale−11.1K$13.05−$144.7K−1.5%707.3K after
Feb 25, 2025 (view filing)Feb 214 daysShah GauravCEOSSale−16.3K$10.58−$172.5K−2.1%772.7K after
Apr 14, 2025 (view filing)Apr 104 daysShah GauravCEOPPurchase+20.0K$5.08+$101.6K+2.6%792.7K after

See all 20 trades at RCKT